Needham & Company LLC reiterated their buy rating on shares of Ascend Wellness (OTC:AAWH – Get Rating) in a research note published on Wednesday, Benzinga reports. The firm currently has a $2.75 target price on the stock.
Separately, Cantor Fitzgerald assumed coverage on Ascend Wellness in a research report on Friday, February 10th. They set a neutral rating on the stock.
Ascend Wellness Trading Up 4.4 %
Shares of OTC AAWH opened at $1.19 on Wednesday. The stock’s 50 day moving average price is $1.30 and its two-hundred day moving average price is $1.64. Ascend Wellness has a 52-week low of $0.98 and a 52-week high of $4.23. The company has a debt-to-equity ratio of 1.67, a quick ratio of 0.92 and a current ratio of 1.59.
Ascend Wellness Company Profile
Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods. Its cannabis product categories include flowers, pre-rolls, concentrates, vapes, edibles, and other cannabis-related products. As of December 31, 2021, the company operated 20 retail locations.
- Get a free copy of the StockNews.com research report on Ascend Wellness (AAWH)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Ascend Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascend Wellness and related companies with MarketBeat.com's FREE daily email newsletter.